SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-143458
Filing Date
2014-04-15
Accepted
2014-04-15 07:27:00
Documents
13
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F d608038d20f.htm 20-F 1535662
2 EX-8.1 d608038dex81.htm EX-8.1 11623
3 EX-12.1 d608038dex121.htm EX-12.1 6369
4 EX-12.2 d608038dex122.htm EX-12.2 6381
5 EX-13.1 d608038dex131.htm EX-13.1 2926
6 EX-13.2 d608038dex132.htm EX-13.2 2940
7 EX-23.1 d608038dex231.htm EX-23.1 1512
  Complete submission text file 0001193125-14-143458.txt   13188456

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT wx-20131231.xml EX-101.INS 1848729
9 XBRL TAXONOMY EXTENSION SCHEMA wx-20131231.xsd EX-101.SCH 116352
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE wx-20131231_cal.xml EX-101.CAL 162395
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wx-20131231_def.xml EX-101.DEF 765470
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE wx-20131231_lab.xml EX-101.LAB 877753
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wx-20131231_pre.xml EX-101.PRE 900988
Mailing Address 288 FUTE ZHONG ROAD WAIGAOQIAO FREE TRADE ZONE SHANGHAI F4 200131
Business Address 288 FUTE ZHONG ROAD WAIGAOQIAO FREE TRADE ZONE SHANGHAI F4 200131 86-21-5046-1111
WuXi PharmaTech (Cayman) Inc. (Filer) CIK: 0001403132 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-33623 | Film No.: 14763709
SIC: 2834 Pharmaceutical Preparations